| Trial ID: | L0450 |
| Source ID: | IRCT20191006044994N1
|
| Associated Drug: |
Rosa damascena
|
| Title: |
Comparison of the effect of Rosa damascena with placebo on liver enzymes in patients with nonalcoholic fatty liver disease(NAFLD): a double-blind randomized clinical trial
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease. <br>Non Alcoholic Fatty Liver Disease;k76.0
|
| Interventions: |
Intervention 1: Intervention group: 500 mg capsules of Rosa damascena,6 capsules per day ;each time 2 capsules(*3), Orally, For12 weeks. Intervention 2: Control group: Placebo (breadcrumbs), 500 mg capsule containing breadcrumbs, 6 capsules daily, three
|
| Outcome Measures: |
Alt(Alanin transaminase). Timepoint: Onset and 12th week of study(End of study). Method of measurement: Hitachi-912 biochemistery instrument.;Ast(Aspartate transaminase). Timepoint: Onset and 12th week of study(End of study). Method of measurement: Hitachi-912 biochemistery instrument.nan
|
| Sponsor/Collaborators: |
Iran University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years80 years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
80
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The block randomization method is used using 4-way blocks and a random number table.Interventions A and B define six b
|
| Start Date: |
11/11/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
17 December 2019
|
| Locations: |
Iran (Islamic Republic of);Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/42819
|
